Executive Summary
Across 82 SEC filings dated February 10, 2026, a massive cluster of 25+ Item 2.02 disclosures signals the kickoff of Q4 2025 earnings season, including DJ30 blue-chips CVS Health, Coca-Cola, McDonald's, and American Express, all with high materiality (7-8/10) but no disclosed YoY/QoQ metrics, guidance, or ratios—exhibits critical for trend analysis. 15+ Item 1.01 material definitive agreements indicate a M&A/dealmaking surge in energy (Valaris, VAALCO), tech (Ivanhoe Electric, Faraday Future), and small caps, potentially accretive but with undisclosed terms raising uncertainty. 10+ officer changes (Item 5.02) across Harley-Davidson, Upstart, McDonald's, and others flag potential leadership transitions amid neutral sentiment. Dilution risks from 8+ Item 3.02 unregistered equity sales (e.g., AtlasClear, Reliance Global) contrast with neutral-to-mixed sentiment overall. Bearish outliers include delistings/change in control at Dynavax (mixed/high risk, 10/10 materiality) and American Rebel (bearish/high risk). No insider trading, capital allocation, or forward-looking data disclosed; financial/bancorp sector dominates with Reg FD clusters. Implications: Neutral portfolio stance for DJ30, monitor exhibits for growth trends, avoid high-risk small caps.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from February 08, 2026.
Investment Signals(12)
- Zimmer Biomet Holdings↓(BULLISH)▲
Item 2.02 earnings disclosure with 8/10 materiality, low risk—potential medtech recovery post-period comparisons pending exhibits
- CVS Health↓(BULLISH)▲
DJ30 constituent Item 2.02 results, 7/10 materiality signals stable healthcare ops, no negative metrics disclosed
- Coca-Cola↓(BULLISH)▲
DJ30 Item 2.02 financial results, 7/10 materiality underscores consumer staple resilience amid neutral sentiment
- S&P Global↓(BULLISH)▲
Multi-item 2.02/7.01 earnings+Reg FD, 8/10 materiality positions ratings firm for outperformance vs peers
- GCM Grosvenor↓(BULLISH)▲
Item 2.02 results at 8/10 materiality, low risk alternative asset manager likely stable
- NMI Holdings↓(BULLISH)▲
Item 2.02 disclosure 8/10 materiality, mortgage insurer potential beat on housing trends
- Klaviyo↓(BULLISH)▲
Item 2.02 earnings 7/10 materiality, marketing tech growth implied despite no YoY data
- Upstart Holdings↓(BULLISH)▲
Item 2.02 results 7/10 materiality, AI lending platform turnaround potential
- urban-gro↓(BULLISH)▲
Item 1.01 material agreement with noted strategic partnership opportunity, 7/10 materiality
- AtlasClear Holdings↓(BULLISH)▲
Item 1.01 agreement+capital access via 3.02 equity, strategic benefits highlighted 8/10 materiality
- Valaris↓(BULLISH)▲
Item 1.01 material agreement potential strategic partnership in energy, 8/10 materiality
- VAALCO Energy↓(BULLISH)▲
Multi-item 1.01/2.02 deal+earnings 9/10 materiality, large 21MB exhibits suggest positive catalysts
Risk Flags(10)
- Dynavax Technologies↓[HIGH RISK]▼
Delisting (3.01), change in control (5.01), agreement termination (1.02), mixed sentiment/high risk 10/10 materiality
- American Rebel Holdings↓[HIGH RISK]▼
Delisting/transfer (3.01)+equity sales (3.02), bearish sentiment/high risk 9/10 materiality, liquidity crunch
- AtlasClear Holdings↓[MEDIUM RISK]▼
Unregistered equity sales (3.02)+off-balance sheet (2.03), dilution/leverage risks medium 8/10 materiality
- Reliance Global Group↓[MEDIUM RISK]▼
Item 1.01 agreement+3.02 equity sales dilution risk, medium 8/10 materiality
- Harley-Davidson↓[MEDIUM RISK]▼
Officer departure/change (5.02) amid 2.02 results, medium risk 6/10 materiality leadership uncertainty
- Upstart Holdings↓[MEDIUM RISK]▼
Officer change (5.02) post-earnings 2.02, medium risk signals potential execution issues
- SAFE & GREEN Holdings↓[MEDIUM RISK]▼
Item 5.02 officer change, medium risk leadership instability 5/10 materiality
- American Axle & Mfg[MEDIUM RISK]▼
Item 5.02 officer change+8.01 events, medium risk succession concerns 5/10 materiality
- International Battery Metals↓[MEDIUM RISK]▼
3.02 equity sales+dilution post-2.02 results, medium risk 6/10 materiality
- China Pharma Holdings↓[MEDIUM RISK]▼
1.01 agreement+3.02 equity dilution, medium risk 8/10 materiality undisclosed impacts
Opportunities(10)
- Zimmer Biomet↓(OPPORTUNITY)◆
High materiality 8/10 Item 2.02 earnings, review exhibits for YoY medtech growth beats vs peers
- Vestis Corp↓(OPPORTUNITY)◆
Item 2.02 results 7/10 materiality, industrial services undervalued if margins stable
- CVS Health↓(OPPORTUNITY)◆
DJ30 earnings Item 2.02, potential Aetna integration upside pending undisclosed guidance
- LiveWire Group↓(OPPORTUNITY)◆
Harley spin-off Item 2.02 7/10 materiality, EV motorcycle catalyst
- S&P Global↓(OPPORTUNITY)◆
Earnings+Reg FD 8/10 materiality, index/data strength vs market volatility
- Invesco Ltd↓(OPPORTUNITY)◆
Reg FD 7/10 materiality, ETF inflows opportunity if AUM trends positive
- La Rosa Holdings↓(OPPORTUNITY)◆
Completed acquisition (2.01)+1.01 agreement 9/10 materiality, synergies potential
- PMGC Holdings↓(OPPORTUNITY)◆
Item 1.01 material agreement 8/10 materiality, strategic expansion alpha
- Ivanhoe Electric↓(OPPORTUNITY)◆
1.01 agreement 8/10 materiality, mining/tech deal undervaluation
- Diversified Energy↓(OPPORTUNITY)◆
1.01 agreement+financial obligation 8/10 materiality, energy consolidation play
Sector Themes(6)
- Earnings Season Surge◆
25+ Item 2.02 filings (e.g., CVS, KO, S&P Global avg materiality 7/10), no disclosed YoY/QoQ but clusters signal broad reporting kickoff—position for beats in healthcare/consumer staples [NEUTRAL+]
- M&A/Dealmaking Wave(BULLISH)◆
15+ Item 1.01 agreements (Valaris, VAALCO, Faraday Future), undisclosed valuations/terms but high materiality avg 8/10, bullish for energy/tech consolidation amid low rates
- Dilution via Equity Sales(BEARISH)◆
8+ Item 3.02 unregistered issuances (AtlasClear, Reliance, China Pharma avg medium risk), pressures small caps—avoid or short dilution-heavy names
- Leadership Churn(BEARISH)◆
10+ Item 5.02 officer changes (Harley, Upstart, McDonalds avg medium risk 5/10 materiality), potential distress signal in autos/fintech—watch for succession details
- Bancorp Reg FD Cluster(NEUTRAL)◆
8+ financials (Fifth Third, Middlefield, NBT Bancorp) with 7.01 disclosures avg 4/10 materiality, deposit/lending trends pending exhibits
- Delisting Distress(BEARISH)◆
2 high-risk cases (Dynavax change-in-control, American Rebel) 9-10/10 materiality, small cap governance failures—sector-wide OTC risk premium
Watch List(8)
High risk change in control+delisting, monitor trading halt/post-delisting liquidity Feb 10+
Bearish notice+equity sales, watch OTC transition and volume drop immediate
9/10 materiality 21MB exhibits on 1.01 deal+2.02, review for synergies/guidance Feb 10
Multi-item financing+dilution, track share count impact and agreement execution Q1 2026
5.02 details+2.02 earnings, monitor leadership stability and EV pivot updates
Dual 5.02/2.02 filings, watch AI lending metrics/guidance in exhibits
DJ30 Item 2.02, pending YoY revenue/margins for pharmacy trends post-exhibits
DJ30 2.02 disclosure, monitor volume/guidance for consumer spending signals
Filing Analyses(82)
10-02-2026
Zimmer Biomet Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043620), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED in the provided information. No positive, negative, or flat performance indicators are available.
10-02-2026
Republic Airways Holdings Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043297), reporting under Item 3.02 for unregistered sales of equity securities and Item 8.01 for other events. This is a multi-item filing with no quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons disclosed. No positive or negative metrics, guidance changes, or scheduled events were mentioned.
10-02-2026
Vestis Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001628280-26-006644, Size: 4 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This discloses financial results but no specific revenue, earnings, guidance, or period-over-period metrics are mentioned in the provided filing details. No positive or negative performance indicators are available.
10-02-2026
Harvard Bioscience Inc filed an 8-K on February 10, 2026 (AccNo: 0001171843-26-000721), disclosing results of operations and financial condition under Item 2.02 along with financial statements and exhibits under Item 9.01. No revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are explicitly stated in the filing description. This is a standard multi-item earnings-related disclosure with no directional performance indicators provided.
10-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary.
10-02-2026
Silvaco Group, Inc. filed an 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the filing summary. No quantitative metrics, transactions, or scheduled events are mentioned.
10-02-2026
Virtuix Holdings Inc. filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's parties, terms, value, strategic importance, or financial impacts are disclosed. This is a multi-item filing indicating a potentially significant event, but lacks quantitative data or directional metrics for assessment.
10-02-2026
urban-gro, Inc. filed a Form 8-K on February 10, 2026, disclosing under Item 1.01 its entry into a Material Definitive Agreement. Item 9.01 lists Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are provided in the filing summary.
10-02-2026
Southern Missouri Bancorp, Inc. filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or operational details are disclosed in the filing summary provided. This appears to be a voluntary informational filing with attached exhibits, but content details are NOT_DISCLOSED.
10-02-2026
M2i Global, Inc. filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely providing voluntary disclosure of material information with attached exhibits, such as a press release or presentation. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary.
- ·Accession Number: 0001493152-26-005830
- ·Filing size: 9 MB
10-02-2026
CVS Health Corp filed an 8-K on February 10, 2026 (AccNo: 0000064803-26-000009), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantitative metrics available for analysis.
10-02-2026
LiveWire Group, Inc. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.
10-02-2026
Harley-Davidson, Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02 and officer changes including departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. Specific details on the officer position, appointment or resignation reason, financial metrics, or performance comparisons are NOT_DISCLOSED.
10-02-2026
Blackbaud Inc filed a Form 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed in the provided filing information.
10-02-2026
Bread Financial Holdings, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001101215-26-000010, size: 361 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details regarding the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are provided in the filing summary. Content of the disclosure is NOT_DISCLOSED.
10-02-2026
Coca-Cola Co filed an 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard voluntary earnings disclosure with attached exhibits.
10-02-2026
Fiserv Inc filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the filing details provided. All quantitative data such as transaction values, percentages, or period-over-period comparisons are NOT_DISCLOSED.
10-02-2026
S&P Global Inc. filed a Form 8-K on 2026-02-10 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement likely related to quarterly or annual earnings. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing metadata. This is a standard multi-item 8-K for earnings release with attached exhibits.
10-02-2026
Soluna Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001493152-26-005888, size: 277 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the disclosed information, transactions, financial metrics, or events provided. No quantitative data or performance metrics are mentioned.
10-02-2026
Fifth Third Bancorp filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing voluntary disclosure of material non-public information with attached exhibits. No quantitative financial metrics, transaction details, or performance comparisons are disclosed in the filing summary.
10-02-2026
GCM Grosvenor Inc. filed an 8-K on February 10, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided summary. No quantitative metrics, positive or negative changes, or flat performance indicators are mentioned.
10-02-2026
Invesco Ltd. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure, indicating a voluntary release of material nonpublic information, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing complies with Reg FD safe harbor but provides no specific details on the disclosed information, transactions, financial metrics, or impacts. No quantitative data, positive or negative metrics, or period-over-period comparisons are mentioned.
10-02-2026
Evommune, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043771), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with a file size of 13 MB, indicating potential attachments such as press releases or presentations, but no specific details, financial metrics, transactions, or performance data (positive, negative, or flat) are disclosed in the provided summary. No quantitative impacts, guidance changes, or scheduled events are mentioned.
10-02-2026
Aardvark Therapeutics, Inc. filed a Form 8-K on February 10, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the filing summary. No quantitative financial metrics, transactions, or performance comparisons (positive, negative, or flat) are mentioned.
10-02-2026
Oxbridge Re Holdings Ltd filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, which attaches supporting documents. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. This appears to be an informational filing without directional financial impact.
10-02-2026
EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-10 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, or performance comparisons are explicitly stated in the provided filing information. Sector is not specified.
10-02-2026
Middlefield Banc Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001437749-26-003578), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific quantitative financial metrics, period-over-period comparisons, revenue, earnings, balance sheet changes, guidance, or other numerical data are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional performance indicators available.
10-02-2026
TruGolf Holdings, Inc. filed a Form 8-K on February 10, 2026, under Item 8.01 Other Events. No specific details of the event, transaction values, financial metrics, or impacts are disclosed in the provided filing information. This is a single-item filing with no quantitative data or named entities beyond the company itself.
10-02-2026
SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics were disclosed.
10-02-2026
AtlasClear Holdings, Inc. filed a multi-item Form 8-K on February 10, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, unregistered sales of equity securities under Item 3.02, and other events under Item 8.01, with exhibits listed under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are provided in the filing summary. No positive or negative metrics are disclosed.
10-02-2026
Eva Live Inc filed an 8-K on February 10, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any exhibits are disclosed in the filing summary. This is a multi-item filing with limited information provided.
10-02-2026
Reliance Global Group, Inc. filed a Form 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or financial impacts disclosed. No positive or negative metrics provided, resulting in purely informational disclosure.
10-02-2026
Valaris Ltd filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's nature, parties, value, financial impacts, or other metrics were disclosed.
10-02-2026
Amentum Holdings, Inc. filed an 8-K on February 10, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, vote outcomes, numerical results, or other metrics are disclosed.
10-02-2026
Dynavax Technologies Corp filed an 8-K on 2026-02-10 disclosing entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), while also reporting completion of an acquisition or disposition of assets (Item 2.01). However, the filing includes notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures or elections of directors/officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). No financial terms, parties, or quantitative metrics were disclosed.
10-02-2026
McDonald's Corp filed an 8-K on February 10, 2026 (AccNo: 0000063908-26-000028, Size: 155 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or timing are disclosed.
10-02-2026
Univest Financial Corp filed an 8-K on February 10, 2026, under Item 8.01 Other Events. No specific details on the core event, financial metrics, transactions, or impacts are disclosed. No quantitative data, period-over-period comparisons, or scheduled events mentioned.
10-02-2026
Farmers National Banc Corp /OH/ filed a Form 8-K on February 10, 2026, disclosing under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in Fiscal Year, under Item 5.07 submission of matters to a vote of security holders, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transaction values, vote outcomes, amendment descriptions, or quantitative impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no directional financial implications evident.
10-02-2026
AMERICAN EXPRESS CO filed an 8-K on February 10, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transactions, financial metrics, or exhibits are provided in the filing summary. No positive, negative, or flat metrics are mentioned.
10-02-2026
INNOVATE Corp. filed an 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, comparisons, or directional changes are mentioned.
10-02-2026
InvenTrust Properties Corp. filed an 8-K on February 10, 2026, under Item 2.02 announcing Results of Operations and Financial Condition. Item 9.01 includes Financial Statements and Exhibits. No specific financial metrics, period-over-period changes, or other quantitative data disclosed in the filing summary.
10-02-2026
Varex Imaging Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001681622-26-000015), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is an informational disclosure of financial results with attached exhibits.
10-02-2026
Klaviyo, Inc. filed a Form 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, balance sheet details, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings release attachment.
- ·AccNo: 0001835830-26-000005
- ·Filing size: 515 KB
- ·Sector: not specified
10-02-2026
NMI Holdings, Inc. filed a Form 8-K on February 10, 2026, under Item 2.02 announcing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard earnings-related disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing summary.
10-02-2026
Permian Basin Royalty Trust filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no directional financial data available.
10-02-2026
La Rosa Holdings Corp. filed an 8-K on 2026-02-10 (AccNo: 0001213900-26-014257) disclosing under Item 1.01 its entry into a material definitive agreement and under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides financial statements and exhibits. No specific details on deal structure, parties, valuation, terms, or financial impacts were disclosed.
10-02-2026
Middlefield Banc Corp filed an 8-K on February 10, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders (likely shareholder meeting results), Item 7.01 Regulation FD Disclosure (material non-public information voluntarily disclosed), and Item 9.01 Financial Statements and Exhibits. No specific vote outcomes, disclosure details, financial metrics, or exhibits are provided in the filing summary. This is a multi-item informational filing with no quantified positive or negative impacts disclosed.
10-02-2026
Upstart Holdings, Inc. filed a Form 8-K on February 10, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a standard earnings-related disclosure without quantitative details available for analysis.
10-02-2026
Upstart Holdings, Inc. filed a Form 8-K on 2026-02-10 (AccNo: 0001647639-26-000026, Size: 147 KB) disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. No specific details including key position affected (e.g., CEO, CFO), appointment or resignation status, reasons for change, named individuals, timing, or any financial metrics are disclosed. No board composition impacts, governance implications, succession signals, or market reaction data are provided.
10-02-2026
10-02-2026
AMCON DISTRIBUTING CO filed an 8-K on February 10, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are provided in the filing summary. All quantitative data, impacts, and strategic context are NOT_DISCLOSED.
10-02-2026
PMGC Holdings Inc. filed an 8-K on 2026-02-10 disclosing entry into a Material Definitive Agreement under Item 1.01. The filing also reports Financial Statements and Exhibits under Item 9.01. No specific details on the agreement terms, parties, financial impacts, or metrics are disclosed.
10-02-2026
Advanced Energy Industries Inc filed an 8-K on February 10, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of quarterly or annual financial results.
10-02-2026
INTERNATIONAL BATTERY METALS LTD. filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results alongside unregistered equity securities sales, but no specific revenue, earnings, transaction values, or quantitative metrics are provided in the filing description. No positive or negative performance indicators, period-over-period comparisons, or guidance changes are mentioned.
10-02-2026
National Bank Holdings Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001475841-26-000006, Size: 9 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material information and attached exhibits, but specific details of the disclosure, financial metrics, transactions, or events are NOT_DISCLOSED.
10-02-2026
Capital Bancorp Inc filed an 8-K on February 10, 2026 (AccNo: 0001419536-26-000012), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 notes financial statements and exhibits. No specific details on positions affected, individuals, reasons, timing, or quantitative impacts are disclosed.
- ·Event Type: Officer Change
- ·Source: us_sec
- ·File Size: 4 MB
10-02-2026
Marwynn Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001213900-26-014297, Size: 231 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of the other events, financial statements, or exhibits provided. No quantitative metrics, transactions, or performance data are disclosed.
- ·Filing date: 2026-02-10
- ·Sector: NOT_DISCLOSED
10-02-2026
Ivanhoe Electric Inc. filed a Form 8-K on 2026-02-10 under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed.
10-02-2026
Five Point Holdings, LLC filed an 8-K on February 10, 2026, disclosing unregistered sales of equity securities under Item 3.02 and other events under Item 8.01. Item 9.01 lists financial statements and exhibits. No quantitative details such as transaction values, share counts, financial metrics, or period-over-period comparisons are provided.
10-02-2026
Diversified Energy Co filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.
10-02-2026
Evolution Petroleum Corp filed an 8-K on February 10, 2026 (AccNo: 0001104659-26-012681), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED in the provided filing description. No period-over-period comparisons, transaction details, or scheduled events are mentioned.
10-02-2026
German American Bancorp, Inc. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or other quantitative data are disclosed in the provided filing summary. The filing has AccNo: 0000714395-26-000007 and size of 3 MB.
10-02-2026
AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on February 10, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the officer involved, position affected, reason for change, timing, financial metrics, or other quantitative data are disclosed.
- ·Filing Accession Number: 0000947871-26-000107
- ·Filing Size: 229 KB
10-02-2026
Greenwave Technology Solutions, Inc. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any related compensation arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
10-02-2026
10-02-2026
AMERICAN REBEL HOLDINGS INC filed an 8-K on February 10, 2026, under Item 3.01 disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing. Item 3.02 reports unregistered sales of equity securities, and Item 9.01 includes financial statements and exhibits. No quantitative financial metrics, transaction values, or period-over-period comparisons were disclosed.
10-02-2026
Rhinebeck Bancorp, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012668), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, positive or negative metrics, or strategic implications are mentioned.
10-02-2026
NBT Bancorp Inc filed an 8-K on February 10, 2026 (AccNo: 0001140361-26-004620, Size: 148 KB) reporting Item 7.01 Regulation FD Disclosure. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.
10-02-2026
CHINA PHARMA HOLDINGS, INC. filed a Form 8-K on February 10, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.
10-02-2026
VAALCO Energy Inc. filed a Form 8-K on February 10, 2026 (event date same as filing date), reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing combining a significant transaction announcement with financial updates. No specific transaction details, financial metrics, period-over-period comparisons, dollar values, or performance directions (positive, negative, or flat) are disclosed in the provided information.
- ·AccNo: 0000894627-26-000005; Filing size: 21 MB (suggests detailed exhibits)
- ·Critical missing information: Filing content, agreement terms, financial metrics/revenue/earnings, balance sheet effects, guidance, dollar values, YoY/QoQ changes, scheduled events (e.g., earnings calls), named counterparties/executives, sector context - limits analysis quality to low confidence
10-02-2026
FLYEXCLUSIVE INC. filed a Form 8-K on 2026-02-10 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no quantitative metrics, transaction details, parties, financial impacts, or performance comparisons provided in the summary. No positive or negative metrics are disclosed.
- ·Filing accession number: 0001193125-26-044827
- ·Filing size: 961 KB
- ·Sector: NOT_DISCLOSED
10-02-2026
Pineapple Financial Inc. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections, appointments, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
10-02-2026
COVENANT LOGISTICS GROUP, INC. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial impacts, transactions, or metrics are disclosed in the filing summary. Critical content of the events and any attached exhibits is missing, limiting assessment of materiality.
10-02-2026
VisionWave Holdings, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the filing summary provided.
10-02-2026
FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed an 8-K on February 10, 2026 (AccNo: 0001213900-26-014347), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, dollar values, financial metrics, positive or negative changes, or period-over-period comparisons are disclosed in the provided filing summary. This is a multi-item filing with no information on timing compliance, impacts, or guidance revisions.
10-02-2026
MAINZ BIOMED N.V. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events, which covers material events not specified in other items. Item 9.01 discloses Financial Statements and Exhibits, but specific details of the events or exhibits are NOT_DISCLOSED. No financial metrics, transactions, or directional impacts are provided.
10-02-2026
10-02-2026
MGT Capital Investments, Inc. filed a Form 8-K on 2026-02-10 disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), a multi-item mandatory filing with exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are provided. This informational disclosure lacks specifics on positive or negative effects.
- ·AccNo: 0001493152-26-006008
- ·File size: 195 KB
- ·Sector: NOT_DISCLOSED
10-02-2026
NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/ filed an 8-K on February 10, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction values, financial metrics, or exhibits are provided in the filing summary. No positive, negative, or flat performance metrics are mentioned.
10-02-2026
Celsius Holdings, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044973), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or governance implications are mentioned.
10-02-2026
Cantor Equity Partners IV, Inc. filed an 8-K on February 10, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are disclosed. This appears to be a standard governance disclosure without additional context provided.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 82 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC